Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
20 participants
INTERVENTIONAL
2022-07-18
2023-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In addition to cognitive screening prior to onset of rTMS, language assessments will be conducted before, during and after the intervention. An eyetracking-while-listening experiment will also be conducted before and after the intervention to investigate morphosyntactic processing.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Repetitive Transcranial Magnetic Stimulation Therapy on Lower Extremity Motor Development in Stroke Patients
NCT05554861
Effects of rTMS on Brain Activation in Aphasia
NCT03292471
rTMS in Aphasic Patients With Neuroimage Assessments
NCT03059225
The Effects of Repetitive Transcranial Magnetic Stimulation in Patients With Alzheimer's Disease
NCT05102045
Transcranial Magnetic Stimulation to Improve Speech in Aphasia
NCT00608582
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In addition to cognitive screening prior to onset of rTMS, language assessments will be conducted before, during and after the intervention. The language assessment will be conducted using the Turkish Aphasia Language Assessment Test (ADD) and sets of pictures used to assess naming performance. ADD will be carried out before and after the intervention. Six picture sets will be used, one at baseline, four on different days during the intervention, and the last one immediately after the last day of the intervention. Cognitive screening will be conducted at baseline using the digit span test and Raven's colored progressive matrices. In addition, a pre- and post-treatment eyetracking-while-listening experiment will be conducted to investigate morphosyntactic processing in Turkish and to examine whether the two brain stimulation interventions differentially affect online (dynamic, time-dependent) measures of morphosyntactic processing. The eyetracking paradigm will request the participants to listen to Turkish sentences varying in morphosyntactic complexity (canonical versus noncanonical sentences) and to look at the picture (out of two pictures presented on the screen) corresponding to the sentence they are listening to.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Right frontal 1 Hz rTMS
Low-frequency (1 Hz) inhibitory rTMS will be administered to right inferior frontal gyrus with the following parameters:
Frequency: 1 Hz Stimulation site: Right IFG (as determined using EEG 10-20 system) Intensity: 100% of motor threshold Dosage: 20 minutes per day Duration: 10 days over 2 weeks (no stimulation during weekends)
rTMS over right frontal target
Low frequency (1 Hz) rTMS over right inferior frontal gyrus
Right temporal 1 Hz rTMS
Low-frequency (1 Hz) inhibitory rTMS will be administered to right posterior superior temporal gyrus with the following parameters:
Frequency: 1 Hz Stimulation site: Right posterior superior temporal gyrus (as determined using EEG 10-20 system) Intensity: 100% of motor threshold Dosage: 20 minutes per day Duration: 10 days over 2 weeks (no stimulation during weekends)
rTMS over right temporal target
Low frequency (1 Hz) rTMS over right posterior superior temporal gyrus
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
rTMS over right frontal target
Low frequency (1 Hz) rTMS over right inferior frontal gyrus
rTMS over right temporal target
Low frequency (1 Hz) rTMS over right posterior superior temporal gyrus
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Normal or corrected-to-normal vision and hearing,
* Aphasia following cerebrovascular accident,
* Cerebrovascular accident at least 6 months prior to enrolment in the study,
* Satisfying current TMS safety guidelines (Rossi et al. 2009, 2021), which are:
* No previous history of epilepsy,
* No implant (e.g., cochlear implant) or stimulator (e.g., deep brain stimulation) in the head which may interact with the magnetic field,
* No use of central nervous system active drugs that lower seizure threshold (as listed in the aforementioned guidelines)
Exclusion Criteria
* Impaired and uncorrected vision or hearing,
* No aphasia symptoms following cerebrovascular accident,
* Time since cerebrovascular accident less than 6 months,
* Violating current TMS safety guidelines (Rossi et al. 2009, 2021). In other words:
* Having a previous history of epilepsy,
* Having an implant (e.g., cochlear implant) or stimulator (e.g., deep brain stimulation) in the head which may interact with the magnetic field,
* Taking central nervous system active drugs that lower seizure threshold (as listed in the aforementioned guidelines)
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medipol University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Talat Bulut
Assist. Prof. Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Talat Bulut, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Medipol University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
İstanbul Medipol University, Speech, Language and Swallowing Therapy and Research Center (MEDKOM)
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.